Smilow Cancer Hospital expert explains five things you need to know about Lung Cancer

Roy Herbst, M.D., Ph.D., chief of Medical Oncology at Smilow Cancer Hospital, has been researching lung cancer and treating patients with the disease for more than 25 years. He discusses the facts about lung cancer, ways to reduce your risk, and how new treatments are significantly extending life for patients.

Read more

MedStar Washington Hospital Center Now Offering Novel Robotic Platform to Diagnose Lung Conditions

MedStar Washington Hospital Center physicians are using a new innovation designed to help diagnose small peripheral lung nodules with greater precision and accuracy. Auris Health’s Monarch™ Platform offers a flexible robotic endoscope that doctors use to navigate deep into the lungs and obtain tissue samples for biopsy to determine if lung disease or cancer is present.

Read more

Rutgers study examines smoking status, health conditions in older Chinese American men

The findings of the study by the Rutgers Institute for Health, Health Care Policy and Aging Research underscore the need for culturally targeted interventions to prevent and reduce tobacco use, manage chronic disease and screen for lung cancer.

Read more

Lung Cancer Program at NYU Langone Health’s Perlmutter Cancer Center Joins Prestigious Thoracic Surgery Oncology Group

NYU Langone Health has become one of 23 institutions selected to comprise the American Association for Thoracic Surgery’s Thoracic Surgery Oncology Group (TSOG). A North American thoracic surgery clinical trials network, TSOG aims to improve the understanding of thoracic oncologic diseases and enhance the care of patients.

Read more

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer. Pegilodecakin with pembrolizumab and nivolumab shown to be safe in Phase IB study

Read more

Yale Cancer Center researchers show adding radiation after immunotherapy improves survival time for patients with advanced lung cancer

The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).

Read more

Yale Cancer Center researchers show adding radiation after immunotherapy improves survival time for patients with advanced lung cancer

The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).

Read more